Skip to main content

August 2015

Hands on Training Workshop on Nano Drug Delivery System: Synthesis, Characterisation and Cellular Imaging at ICTM

The Institute of Chemical Technology (ICT) Mumbai was established as the Department of Chemical Technology on 1st October, 1933 by the University of Mumbai, through active support of industries and philanthropists. The Institute was most popularly known as UDCT, Mumbai. Research has been an integral part of ICT since its inception and it has created over 500 first generation entrepreneurs. The UDCT grew significantly in stature and was granted autonomy under UGC regulations by the University of Mumbai and further converted in to an Institute on 26th January, 2002. Under the World Bank TEQIP programme, the Maharashtra government granted it full autonomy in June 2004. Due to the recommendations of the Government of Maharashtra and University of Mumbai, the ICT was granted Deemed University Status by the MHRD on 12th September, 2008, with all provisions of the UGC for funding and support as the state owned deemed university.

A new research by researchers from University of Copenhagen has revealed  If you were intelligent throughout your academic life, chances are you will be more physically-fit as you grow older. The study is published in the Journal of Aging and Health.

The US Food and Drug Administration (FDA) has accepted leading global pharmaceutical company, Teva Pharmaceutical Industries Ltd's New Drug Application (NDA) for SD-809 (deutetrabenazine) for the treatment of chorea associated with Huntington disease (HD). It is  a rare and fatal neurodegenerative disorder caused by the progressive breakdown of nerve cells in the brain that affects about five to seven people per 100,000 in western countries, according to the World Health Organisation.

An international team of researchers have sequenced the whole genome of an octopus, revealing unique genomic features that likely played a role in the evolution of traits such as large complex nervous systems and adaptive camouflage. They sequenced the genome of the California two-spot octopus, the first cephalopod ever to be fully sequenced, and mapped gene expression profiles in 12 different tissues. The study is published in Nature. Cephalopods are the most intelligent invertebrates and have demonstrated elaborate problem-solving and learning behaviors.

[adsense:336x280:8701650588]

Walk in interview for B.Pharm/M.Pharm as Manager/Assistant Manager, Senior Executive/ Executive, Executive Officer in Gufic Lifesciences | 19 Posts - not for freshers

We, Gufic Lifesciences Private Limited is coming with manufacturing facilities of PIC's, MHRA, USFDA requirement for formulation of Lyophilization injectables at Navsari (Gujarat) for which we are looking for competent candidates.

Post: Manager/Assistant Manager, Senior Executive/ Executive, Executive Officer

Join as Assistant Manager Operations (B.Pharm/D.Pharm) in Apollo Hospital, Chennai

Apollo Hospitals was the forerunner of integrated healthcare in Asia, as well as globally. Today, the group's futuristic vision has ensured that it has been in a position of strength at every touch point of the healthcare delivery chain. Its presence encompasses over 10,000 beds across 64 hospitals, more than 2200 pharmacies, over 100 primary care & diagnostic clinics, 115 telemedicine units across 9 countries, health insurance services, global projects consultancy, 15 academic institutions and a Research Foundation with a focus on global clinical trials, epidemiological studies, stem-cell and genetic research.

Post: Assistant Manager Operations

GLOBAL CANCER SUMMIT – 2015

"Cancer begins and ends with people. In the midst of scientific abstraction, it is somethimes possible to forget this one basic fact... Doctors treat diseases, but they also treat people, and this precondition of their professional existence sometimes pulls them in two directions at once."
Cancer is one of the leading causes of death around the globe. It is also a disease that has many misconceptions around it. Many people are ignorant about the disease and its vicious impact. It is perhaps the most talked about disease but least understood one.
To help understand, comprehend and devise a protection plan against this malady, we -- BioGenesis – The Euro-Indian Health Cluster (India), Global Cancer Foundation, Indian Council of Medical Research (Government of India) and supported by Clinton Foundation (USA) -- cordially invite you to attend the "Global Cancer Summit-2015 from 18th, 19th and 20th November 2015 at J.N.Tata Auditorium, Indian Institute of Sciences Bengaluru, India.

DATA INTEGRITY NON-COMPLIANCES – THE GOOD, BAD AND UGLY

ABOUT AUTHORS
Krishnendu Singha
Manager – Quality Assurance
[The author is a Quality Assurance professional of a leading MNC]
Krish_singha2007@yahoo.co.in

focus in the areas of pain management and addiction medicine, announced the approval by the US Food and Drug Administration (FDA) of a Supplemental New Drug Application (sNDA) for a new formulation of Onsolis (fentanyl buccal soluble film) CII for the management of breakthrough pain in patients with cancer who are opioid tolerant. Onsolis is separately licensed by BDSI in Taiwan and South Korea.